Cargando…

Classification molecular subtypes of hepatocellular carcinoma based on PRMT-related genes

Background: Recent studies highlighted the functional role of protein arginine methyltransferases (PRMTs) catalyzing the methylation of protein arginine in malignant progression of various tumors. Stratification the subtypes of hepatocellular carcinoma (HCC) is fundamental for exploring effective tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Liwen, Hu, Qiuyue, Zhang, Yize, Sun, Xiangyi, Sun, Ranran, Ren, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992644/ https://www.ncbi.nlm.nih.gov/pubmed/36909154 http://dx.doi.org/10.3389/fphar.2023.1145408

Ejemplares similares

Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma
por: Zhang, Jianxiang, et al.
Publicado: (2023)

Molecular subtypes and scoring tools related to Foxo signaling pathway for assessing hepatocellular carcinoma prognosis and treatment responsiveness
por: Tu, Sheng, et al.
Publicado: (2023)

The core role of macrophages in hepatocellular carcinoma: the definition of molecular subtypes and the prognostic risk system
por: Wang, Qiaona, et al.
Publicado: (2023)

MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway
por: Bao, Jie, et al.
Publicado: (2018)

An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
por: Guizhen, Zhang, et al.
Publicado: (2023)

The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
por: Guizhen, Zhang, et al.
Publicado: (2022)

Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites
por: Zou, Yawen, et al.
Publicado: (2023)

Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma
por: Zhang, Yingying, et al.
Publicado: (2020)

HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma
por: He, Hui, et al.
Publicado: (2020)

A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma
por: Wei, Nan, et al.
Publicado: (2022)

Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma
por: Zhu, Yi-Pan, et al.
Publicado: (2023)

PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration
por: Liu, Xin, et al.
Publicado: (2021)

The Protective Function of PRMT1 in Alcohol‐Induced Hepatocellular Carcinoma
por: Jeong, Jong‐Min, et al.
Publicado: (2020)

The Role of the PRMT5–SND1 Axis in Hepatocellular Carcinoma
por: Wright, Tanner, et al.
Publicado: (2021)

Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs
por: Du, Fengxia, et al.
Publicado: (2022)

A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma
por: Mao, Da, et al.
Publicado: (2022)

Characteristic of molecular subtypes based on PANoptosis-related genes and experimental verification of hepatocellular carcinoma
por: Ren, Haitao, et al.
Publicado: (2023)

Immunotherapies for advanced hepatocellular carcinoma
por: Sun, Li-Yang, et al.
Publicado: (2023)

Effects of Glycolysis-Related Genes on Prognosis and the Tumor Microenvironment of Hepatocellular Carcinoma
por: Zheng, Ju-Yan, et al.
Publicado: (2022)

The role of RNA modification in hepatocellular carcinoma
por: Feng, Qiang, et al.
Publicado: (2022)

Characterization of tumor microenvironment and programmed death-related genes to identify molecular subtypes and drug resistance in pancreatic cancer
por: Yu, Liang, et al.
Publicado: (2023)

Platelet-Related Molecular Subtype to Predict Prognosis in Hepatocellular Carcinoma
por: Zhang, Genhao
Publicado: (2022)

Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy
por: Ding, Lei, et al.
Publicado: (2022)

Computational and In Vitro Analysis of Plumbagin’s Molecular Mechanism for the Treatment of Hepatocellular Carcinoma
por: Wei, Yanfei, et al.
Publicado: (2021)

Classification of the mitochondrial ribosomal protein-associated molecular subtypes and identified a serological diagnostic biomarker in hepatocellular carcinoma
por: Xie, Cong, et al.
Publicado: (2023)

Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineering
por: Sun, Hang, et al.
Publicado: (2023)

Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking
por: Khan, Shakeel Ahmad, et al.
Publicado: (2022)

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Type I PRMT Inhibition Protects Against C9ORF72 Arginine-Rich Dipeptide Repeat Toxicity
por: Premasiri, Alan S., et al.
Publicado: (2020)

m7G regulator-mediated molecular subtypes and tumor microenvironment in kidney renal clear cell carcinoma
por: Chen, Mei, et al.
Publicado: (2022)

Integrated bioinformatics analysis uncovers characteristic genes and molecular subtyping system for endometriosis
por: Wang, Zhaowei, et al.
Publicado: (2022)

An immunogenomic signature for molecular classification in hepatocellular carcinoma
por: Zhuang, Weiwei, et al.
Publicado: (2021)

Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma
por: Zhou, Zheng, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma
por: Li, Yaoting, et al.
Publicado: (2023)

Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma
por: Ye, Jiazhou, et al.
Publicado: (2022)

PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression
por: Cai, Sidong, et al.
Publicado: (2020)

Identification of subtypes of hepatocellular carcinoma and screening of prognostic molecular diagnostic markers based on cell adhesion molecule related genes
por: Sun, Ruge, et al.
Publicado: (2022)

Necroptosis-Related Genes Signatures Identified Molecular Subtypes and Underlying Mechanisms in Hepatocellular Carcinoma
por: Wei, Jianguo, et al.
Publicado: (2022)

Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2023)

Molecular mechanism of Ganji Fang in the treatment of hepatocellular carcinoma based on network pharmacology, molecular docking and experimental verification technology
por: Yang, Miaolun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_19cr5l54ec9imr4ugn5fjaa6u1